{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Acalabrutinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Acalabrutinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Acalabrutinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "acalabrutinib",
    "trial_2_text": "Acalabrutinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Acalabrutinib Supplement: 60 participants will take Acalabrutinib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Acalabrutinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Acalabrutinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.37432345747947693,
      "78": 0.2974090874195099,
      "189": 0.2820397913455963,
      "188": 0.2605741620063782,
      "123": 0.2460048496723175,
      "173": 0.20643681287765503,
      "20": 0.20530331134796143,
      "37": 0.1966368556022644,
      "21": 0.19304703176021576,
      "64": 0.18656480312347412,
      "9": 0.18449799716472626,
      "17": 0.1829015612602234,
      "68": 0.1729390025138855,
      "228": 0.16528452932834625,
      "67": 0.1597430258989334,
      "77": 0.15562616288661957,
      "243": 0.1501947045326233,
      "49": 0.1493769884109497,
      "177": 0.14408083260059357,
      "2": 0.14213036000728607,
      "14": 0.13874034583568573,
      "200": 0.13045459985733032,
      "46": 0.12643767893314362,
      "101": 0.12562575936317444,
      "114": 0.11748234927654266,
      "239": 0.11728530377149582,
      "350": 0.11673229932785034,
      "261": 0.10932677984237671,
      "79": 0.1092332974076271,
      "104": 0.10442148149013519,
      "29": 0.10432067513465881,
      "193": 0.10423901677131653,
      "5": 0.10339429974555969,
      "126": 0.10116244107484818,
      "131": 0.0998959094285965,
      "72": 0.09441936016082764,
      "396": 0.09412238001823425,
      "85": 0.0940159261226654,
      "76": 0.09224138408899307,
      "341": 0.09071236103773117,
      "38": 0.08996521681547165,
      "30": 0.08922205120325089,
      "27": 0.08831769973039627,
      "191": 0.08785415440797806,
      "18": 0.08739983290433884,
      "179": 0.08665501326322556,
      "69": 0.08457490056753159,
      "441": 0.08377013355493546,
      "97": 0.08357629925012589,
      "147": 0.08293028175830841,
      "194": 0.08149626851081848,
      "355": 0.08090736716985703,
      "61": 0.07830875366926193,
      "204": 0.07759961485862732,
      "82": 0.07622135430574417,
      "139": 0.0756586566567421,
      "116": 0.07559143751859665,
      "86": 0.07466448843479156,
      "186": 0.07453154772520065,
      "180": 0.07428190112113953,
      "122": 0.07343646138906479,
      "33": 0.0733778178691864,
      "35": 0.07321742922067642,
      "102": 0.07216858863830566,
      "28": 0.07073814421892166,
      "276": 0.07018507272005081,
      "253": 0.06999075412750244,
      "212": 0.0688784271478653,
      "454": 0.06797511875629425,
      "144": 0.06556699424982071,
      "269": 0.06346520036458969,
      "130": 0.0634189024567604,
      "257": 0.06325004249811172,
      "151": 0.0627724900841713,
      "466": 0.06078825518488884,
      "288": 0.060755591839551926,
      "422": 0.060064610093832016,
      "286": 0.05974620580673218,
      "282": 0.059726208448410034,
      "75": 0.059713397175073624,
      "164": 0.05827293545007706,
      "211": 0.05734885483980179,
      "371": 0.056921541690826416,
      "361": 0.05638522654771805,
      "234": 0.055999960750341415,
      "136": 0.05569702386856079,
      "138": 0.05568942055106163,
      "297": 0.05539976805448532,
      "36": 0.05536719784140587,
      "249": 0.05529108643531799,
      "98": 0.05527172237634659,
      "747": 0.05511607229709625,
      "382": 0.054574597626924515,
      "339": 0.054499249905347824,
      "92": 0.0544692799448967,
      "489": 0.053882889449596405,
      "356": 0.05371171981096268,
      "508": 0.05343320593237877,
      "256": 0.05192412808537483,
      "535": 0.05164004862308502
    },
    "trial_2_ae": {
      "87": 0.37432345747947693,
      "78": 0.2974090874195099,
      "189": 0.2820397913455963,
      "188": 0.2605741620063782,
      "123": 0.2460048496723175,
      "173": 0.20643681287765503,
      "20": 0.20530331134796143,
      "37": 0.1966368556022644,
      "21": 0.19304703176021576,
      "64": 0.18656480312347412,
      "9": 0.18449799716472626,
      "17": 0.1829015612602234,
      "68": 0.1729390025138855,
      "228": 0.16528452932834625,
      "67": 0.1597430258989334,
      "77": 0.15562616288661957,
      "243": 0.1501947045326233,
      "49": 0.1493769884109497,
      "177": 0.14408083260059357,
      "2": 0.14213036000728607,
      "14": 0.13874034583568573,
      "200": 0.13045459985733032,
      "46": 0.12643767893314362,
      "101": 0.12562575936317444,
      "114": 0.11748234927654266,
      "239": 0.11728530377149582,
      "350": 0.11673229932785034,
      "261": 0.10932677984237671,
      "79": 0.1092332974076271,
      "104": 0.10442148149013519,
      "29": 0.10432067513465881,
      "193": 0.10423901677131653,
      "5": 0.10339429974555969,
      "126": 0.10116244107484818,
      "131": 0.0998959094285965,
      "72": 0.09441936016082764,
      "396": 0.09412238001823425,
      "85": 0.0940159261226654,
      "76": 0.09224138408899307,
      "341": 0.09071236103773117,
      "38": 0.08996521681547165,
      "30": 0.08922205120325089,
      "27": 0.08831769973039627,
      "191": 0.08785415440797806,
      "18": 0.08739983290433884,
      "179": 0.08665501326322556,
      "69": 0.08457490056753159,
      "441": 0.08377013355493546,
      "97": 0.08357629925012589,
      "147": 0.08293028175830841,
      "194": 0.08149626851081848,
      "355": 0.08090736716985703,
      "61": 0.07830875366926193,
      "204": 0.07759961485862732,
      "82": 0.07622135430574417,
      "139": 0.0756586566567421,
      "116": 0.07559143751859665,
      "86": 0.07466448843479156,
      "186": 0.07453154772520065,
      "180": 0.07428190112113953,
      "122": 0.07343646138906479,
      "33": 0.0733778178691864,
      "35": 0.07321742922067642,
      "102": 0.07216858863830566,
      "28": 0.07073814421892166,
      "276": 0.07018507272005081,
      "253": 0.06999075412750244,
      "212": 0.0688784271478653,
      "454": 0.06797511875629425,
      "144": 0.06556699424982071,
      "269": 0.06346520036458969,
      "130": 0.0634189024567604,
      "257": 0.06325004249811172,
      "151": 0.0627724900841713,
      "466": 0.06078825518488884,
      "288": 0.060755591839551926,
      "422": 0.060064610093832016,
      "286": 0.05974620580673218,
      "282": 0.059726208448410034,
      "75": 0.059713397175073624,
      "164": 0.05827293545007706,
      "211": 0.05734885483980179,
      "371": 0.056921541690826416,
      "361": 0.05638522654771805,
      "234": 0.055999960750341415,
      "136": 0.05569702386856079,
      "138": 0.05568942055106163,
      "297": 0.05539976805448532,
      "36": 0.05536719784140587,
      "249": 0.05529108643531799,
      "98": 0.05527172237634659,
      "747": 0.05511607229709625,
      "382": 0.054574597626924515,
      "339": 0.054499249905347824,
      "92": 0.0544692799448967,
      "489": 0.053882889449596405,
      "356": 0.05371171981096268,
      "508": 0.05343320593237877,
      "256": 0.05192412808537483,
      "535": 0.05164004862308502
    }
  },
  "safety": {
    "trial_1_safety": 0.38147613406181335,
    "trial_2_safety": 0.38147613406181335
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4781675934791565
  }
}